Logo image of LUXE

LUXEXPERIENCE BV (LUXE) Stock Fundamental Analysis

USA - NYSE:LUXE - US55406W1036 - ADR

7.9 USD
+0.02 (+0.25%)
Last: 10/3/2025, 8:04:00 PM
7.7166 USD
-0.18 (-2.32%)
After Hours: 10/3/2025, 8:04:00 PM
Fundamental Rating

3

LUXE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 122 industry peers in the Specialty Retail industry. While LUXE seems to be doing ok healthwise, there are quite some concerns on its profitability. LUXE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year LUXE was profitable.
LUXE had a positive operating cash flow in the past year.
In the past 5 years LUXE always reported negative net income.
In multiple years LUXE reported negative operating cash flow during the last 5 years.
LUXE Yearly Net Income VS EBIT VS OCF VS FCFLUXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

The Return On Assets of LUXE (-5.51%) is worse than 68.85% of its industry peers.
Looking at the Return On Equity, with a value of -9.22%, LUXE is in line with its industry, outperforming 45.08% of the companies in the same industry.
LUXE has a Return On Invested Capital (2.14%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -5.51%
ROE -9.22%
ROIC 2.14%
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
LUXE Yearly ROA, ROE, ROICLUXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

Looking at the Operating Margin, with a value of 1.47%, LUXE is in line with its industry, outperforming 47.54% of the companies in the same industry.
Looking at the Gross Margin, with a value of 47.67%, LUXE is in the better half of the industry, outperforming 73.77% of the companies in the same industry.
In the last couple of years the Gross Margin of LUXE has remained more or less at the same level.
Industry RankSector Rank
OM 1.47%
PM (TTM) N/A
GM 47.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
LUXE Yearly Profit, Operating, Gross MarginsLUXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LUXE is destroying value.
LUXE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LUXE Yearly Shares OutstandingLUXE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
LUXE Yearly Total Debt VS Total AssetsLUXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

LUXE has an Altman-Z score of 4.49. This indicates that LUXE is financially healthy and has little risk of bankruptcy at the moment.
LUXE has a better Altman-Z score (4.49) than 84.43% of its industry peers.
LUXE has a debt to FCF ratio of 3.92. This is a good value and a sign of high solvency as LUXE would need 3.92 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.92, LUXE is in the better half of the industry, outperforming 67.21% of the companies in the same industry.
LUXE has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
LUXE has a better Debt to Equity ratio (0.15) than 66.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 3.92
Altman-Z 4.49
ROIC/WACC0.29
WACC7.34%
LUXE Yearly LT Debt VS Equity VS FCFLUXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.85 indicates that LUXE should not have too much problems paying its short term obligations.
LUXE has a Current ratio of 1.85. This is amongst the best in the industry. LUXE outperforms 81.97% of its industry peers.
A Quick Ratio of 0.30 indicates that LUXE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.30, LUXE is doing worse than 73.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 0.3
LUXE Yearly Current Assets VS Current LiabilitesLUXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

LUXE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.75%.
The earnings per share for LUXE have been decreasing by -53.29% on average. This is quite bad
EPS 1Y (TTM)-33.75%
EPS 3Y-53.29%
EPS 5YN/A
EPS Q2Q%-474%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%164.6%

3.2 Future

The Earnings Per Share is expected to grow by 91.22% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 49.00% on average over the next years. This is a very strong growth
EPS Next Y-529.8%
EPS Next 2Y91.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year109.56%
Revenue Next 2Y49%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LUXE Yearly Revenue VS EstimatesLUXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
LUXE Yearly EPS VS EstimatesLUXE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 131.67 indicates a quite expensive valuation of LUXE.
LUXE's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of LUXE to the average of the S&P500 Index (27.86), we can say LUXE is valued expensively.
LUXE is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 131.67
Fwd PE N/A
LUXE Price Earnings VS Forward Price EarningsLUXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

LUXE's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. LUXE is more expensive than 62.30% of the companies in the same industry.
LUXE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 51.4
EV/EBITDA 29.59
LUXE Per share dataLUXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as LUXE's earnings are expected to grow with 91.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y91.22%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LUXE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LUXEXPERIENCE BV

NYSE:LUXE (10/3/2025, 8:04:00 PM)

After market: 7.7166 -0.18 (-2.32%)

7.9

+0.02 (+0.25%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)09-25 2025-09-25/bmo
Earnings (Next)11-17 2025-11-17
Inst Owners15.64%
Inst Owner Change-5.09%
Ins Owners0.9%
Ins Owner ChangeN/A
Market Cap1.08B
Analysts76.36
Price Target11.6 (46.84%)
Short Float %5.46%
Short Ratio3.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)539%
Min EPS beat(2)96.08%
Max EPS beat(2)981.91%
EPS beat(4)3
Avg EPS beat(4)308.49%
Min EPS beat(4)-50.98%
Max EPS beat(4)981.91%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.62%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)0.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.74%
Min Revenue beat(4)-4.69%
Max Revenue beat(4)0.39%
Revenue beat(8)3
Avg Revenue beat(8)-1.37%
Revenue beat(12)4
Avg Revenue beat(12)-1.92%
Revenue beat(16)6
Avg Revenue beat(16)-1.54%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.69%
EPS NY rev (1m)0%
EPS NY rev (3m)-59.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.96%
Valuation
Industry RankSector Rank
PE 131.67
Fwd PE N/A
P/S 1.03
P/FCF 51.4
P/OCF 40.76
P/B 2.21
P/tB 3.52
EV/EBITDA 29.59
EPS(TTM)0.06
EY0.76%
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)0.15
FCFY1.95%
OCF(TTM)0.19
OCFY2.45%
SpS7.65
BVpS3.58
TBVpS2.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.51%
ROE -9.22%
ROCE 2.86%
ROIC 2.14%
ROICexc 2.21%
ROICexgc 3.31%
OM 1.47%
PM (TTM) N/A
GM 47.67%
FCFM 2.01%
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
F-Score5
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 3.92
Debt/EBITDA 1.94
Cap/Depr 24.48%
Cap/Sales 0.52%
Interest Coverage 2.5
Cash Conversion 70.23%
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 0.3
Altman-Z 4.49
F-Score5
WACC7.34%
ROIC/WACC0.29
Cap/Depr(3y)134.72%
Cap/Depr(5y)94.09%
Cap/Sales(3y)2.03%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.75%
EPS 3Y-53.29%
EPS 5YN/A
EPS Q2Q%-474%
EPS Next Y-529.8%
EPS Next 2Y91.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%164.6%
Revenue Next Year109.56%
Revenue Next 2Y49%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y280.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year40.96%
EBIT Next 3Y84.01%
EBIT Next 5YN/A
FCF growth 1Y122.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y144.07%
OCF growth 3YN/A
OCF growth 5Y33.41%